国产午夜福利在线观看红一片

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":37,"cheight":29,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500727.png","picWidth":40,"picHeight":29,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

聯系電話:0851-33411018(行政部)   0851-88173360(銷售部)    股票代碼:SZ 002424

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":550,"cheight":381,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889249.png","picWidth":550,"picHeight":381,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
州百靈企業集團制藥股份有限公司
股票代碼:SZ 002424
查看更多最新公告>
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":634,"cheight":56,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500733.png","picWidth":630,"picHeight":56,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

走進百靈

專精于藥 · 專注于人

 貴州百靈企業集團制藥股份有限公司(以下簡稱“貴州百靈”)是一家從事苗藥研發、生產、銷售于一體的醫藥上市公司,注冊資本14.112億元,總資產70.59億元,員工5961人。2010年6月,公司在深圳證券交易所成功上市(股票代碼:SZ 002424)。公司明確圍繞“強化公司在苗藥領域的優勢地位,力爭成為中成藥領域具有核心競爭優勢的企業”為戰略發展目標,以實施“科技苗藥、文化苗藥、生態苗藥”為抓手,致力打造擁有大健康全產業鏈的企業集團。

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":365,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"集團概況","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889219.png","picWidth":360,"picHeight":129,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"集團概況","linkKey":"page","linkUrl":"page.html?id=675381845688348","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":363,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"集團概況","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889221.png","picWidth":"373","picHeight":"129","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"集團概況","linkKey":"page","linkUrl":"page.html?id=675381845688348","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":363,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"藥材基地","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889220.png","picWidth":"363","picHeight":"129","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"藥材基地","linkKey":"page","linkUrl":"page.html?id=675381845688358","jsonData":{}}}
致力于推動苗藥品種的科研創新
實現傳統苗藥現代化、科技化

持續挖掘和探索苗藥寶庫,以傳承

和發揚民族醫藥文化為企業使命

布局中藥材種植產業,加強道地

藥材保護,助力產業化精準扶貧

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":754,"cheight":61,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500735.png","picWidth":754,"picHeight":61,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

產品與服務

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":754,"cheight":61,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500735.png","picWidth":752,"picHeight":61,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
  • 非處方藥
  • 處方藥
  • 大健康產品
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":591,"cheight":57,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500734.png","picWidth":590,"picHeight":57,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

百靈動態

關注百靈了解更多最新資訊

  • 百靈新聞
  • 媒體聚焦
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":243,"cheight":154,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://0745auto.cn/displaynews.html?newsId=707815165394983","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/731705417662478.jpg","picWidth":"274","picHeight":"159","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://0745auto.cn/displaynews.html?newsId=707815165394983","linkUrl":"http://0745auto.cn/displaynews.html?newsId=707815165394983","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":274,"cheight":159,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://0745auto.cn/displaynews.html?newsId=707815014400006","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/729717854437437.png","picWidth":"274","picHeight":"159","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://0745auto.cn/displaynews.html?newsId=707815014400006","linkUrl":"http://0745auto.cn/displaynews.html?newsId=707815014400006","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":274,"cheight":159,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://0745auto.cn/displaynews.html?newsId=707814964068363","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/719609221087247.jpg","picWidth":"274","picHeight":"159","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://0745auto.cn/displaynews.html?newsId=707814964068363","linkUrl":"http://0745auto.cn/displaynews.html?newsId=707814964068363","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":274,"cheight":159,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://0745auto.cn/displaynews.html?newsId=707814955679751","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/707130554318899.jpg","picWidth":"274","picHeight":"159","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://0745auto.cn/displaynews.html?newsId=707814955679751","linkUrl":"http://0745auto.cn/displaynews.html?newsId=707814955679751","jsonData":{}}}

貴州百靈黃連解毒丸順利完成II期臨床試驗 將打造證候類新藥研究典范

貴州百靈參股子公司重慶海扶入選“重慶市2021年第二批擬上市重點培育企業”

貴州百靈糖寧通絡國家級課題穩步推進 糖前干預臨床研究子課題正式啟動

貴州百靈蟬聯貴州企業“雙百強”

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

2021-11-29

2021-11-24

2021-11-09

2021-11-03

重慶海扶距離登陸資本市場更近一步,將與貴州百靈進一步形成資源互補、合作共贏的良好局面,構成醫藥健康領域強勢聯合,不斷提升雙方市場競爭力和綜合盈利能力,為中長期發展賦能詳細>

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":263,"cheight":156,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://0745auto.cn/displaynews.html?newsId=707814964068412","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/719609221087247.jpg","picWidth":"263","picHeight":"157","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://0745auto.cn/displaynews.html?newsId=707814964068412","linkUrl":"http://0745auto.cn/displaynews.html?newsId=707814964068412","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":263,"cheight":157,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889244.webp","picWidth":263,"picHeight":157,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":263,"cheight":158,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://0745auto.cn/displaynews.html?newsId=687373352435825","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049785495651.jpg","picWidth":"263","picHeight":"157","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://0745auto.cn/displaynews.html?newsId=687373352435825","linkUrl":"http://0745auto.cn/displaynews.html?newsId=687373352435825","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":263,"cheight":159,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://0745auto.cn/displaynews.html?newsId=687373352435813","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049785495559.jpg","picWidth":"263","picHeight":"157","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://0745auto.cn/displaynews.html?newsId=687373352435813","linkUrl":"http://0745auto.cn/displaynews.html?newsId=687373352435813","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

2021-11-09

2020-11-01

2020-11-01

2020-11-01

11月8日,國家中醫藥管理局中醫藥科學技術研究專項課題·糖寧通絡系列研究子課題“糖寧通絡片在糖尿病前期人群中的有效性和安全性臨床研究”組長...詳細>

在此次新冠肺炎疫情防控阻擊戰中,貴州百靈企業集團制藥股份有限公司充分發揮企業在藥品生產、物資采購、配送等方面的優勢,充分整合資源,保障藥品生產、供應...詳細>

隨著新型冠狀病毒感染的肺炎疫情持續發酵,作為全國苗藥龍頭企業,貴州百靈通過成立疫情工作領導小組、24小時人員在崗應急機制、提前復工復產等措施...詳細>

證券日報 | 貴州百靈糖寧通絡國家級課題穩步推進 糖前干預臨床研究子課題正式啟動

貴州廣播電視臺 | 一手抓抗疫 一手抓生產

| 制藥人當有濟世心!貴州百靈加班...

安順日報 | 貴州百靈:整合資源全力抗“疫”


中國網財經 | 貴州百靈全力保障防控物資供應

提前復工復產保障藥品穩定供應

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":751,"cheight":64,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889216.png","picWidth":751,"picHeight":64,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

投資者關系

與您共享貴州百靈的發展和成績